ED
NGD

Exane Derivatives’s New Gold Inc NGD Stock Holding History

Exane Derivatives’s Portfolio NGD Stock Details NGD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$684 Buy
639
+1
+0.2% +$1 ﹤0.01% 540
2022
Q1 		$1.15K Hold
638
– – ﹤0.01% 796
2021
Q4 		$957 Sell
638
-177,628
-100% -$256K ﹤0.01% 716
2021
Q3 		$189K Buy
+178,266
New +$245K 0.05% 405
2020
Q3 		– Sell
-1,550,634
Closed -$2.09M – 769
2020
Q2 		$2.09M Sell
1,550,634
-1,394,912
-47% -$1.4M 0.56% 47
2020
Q1 		$1.5M Buy
2,945,546
+432,209
+17% +$350K 0.42% 58
2019
Q4 		$2.61M Buy
2,513,337
+539,624
+27% +$488K 0.48% 67
2019
Q3 		$1.99M Sell
1,973,713
-2,209,699
-53% -$2.69M 0.36% 70
2019
Q2 		$4.02M Sell
4,183,412
-345,870
-8% -$275K 0.7% 32
2019
Q1 		$3.9M Buy
4,529,282
+433,839
+11% +$425K 0.77% 34
2018
Q4 		$3.1M Sell
4,095,443
-490,906
-11% -$397K 0.56% 55
2018
Q3 		$3.68M Buy
4,586,349
+1,121,740
+32% +$1.44M 0.69% 32
2018
Q2 		$7.22M Buy
3,464,609
+1,111,575
+47% +$2.57M 1.21% 17
2018
Q1 		$5.93M Buy
2,353,034
+1,041,733
+79% +$2.93M 1.19% 14
2017
Q4 		$4.31M Buy
1,311,301
+487,995
+59% +$1.64M 0.74% 25
2017
Q3 		$3.05M Buy
823,306
+212,777
+35% +$735K 0.57% 29
2017
Q2 		$1.94M Sell
610,529
-6,016
-1% -$18K 0.42% 66
2017
Q1 		$1.84M Buy
616,545
+253,870
+70% +$821K 0.42% 64
2016
Q4 		$1.27M Buy
362,675
+266,129
+276% +$1.01M 0.25% 77
2016
Q3 		$420K Sell
96,546
-34,821
-27% -$174K 0.06% 164
2016
Q2 		$575K Buy
+131,367
New +$554K 0.1% 125

Other funds holding NGD

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Exane Derivatives's NGD Position: Q2 2022 in Review

Exane Derivatives increased its New Gold Inc (NGD) stake by 0.16% in Q2 2022, buying an estimated $1 and bringing the position to 639 shares worth $684. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Exane Derivatives first reported a position in NGD in Q2 2016 and has held it in 21 quarters since. The position peaked at $7.22M in Q2 2018. 160 funds tracked by Wall St. Rank hold NGD as of Q2 2022.

  • Exane Derivatives held 639 shares of New Gold Inc worth $684 as of Q2 2022.
  • Exane Derivatives bought 1 New Gold Inc share in Q2 2022, an estimated $1.
  • New Gold Inc made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #540 holding.
  • Exane Derivatives first reported a position in New Gold Inc in Q2 2016 and has held it in 21 quarters since.
  • Exane Derivatives's New Gold Inc position peaked at $7.22M in Q2 2018.
  • 160 funds tracked by Wall St. Rank held New Gold Inc as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.